Table 3 Immunohistochemistry results
From: Clinical outcomes of muscle invasive bladder Cancer according to the BASQ classification
CK14 | CK5/6 | GATA3 | FOXA1 | |
|---|---|---|---|---|
< 1% | 60 (60.0%) | 24 (24.0%) | 8 (8.0%) | 15 (15.0%) |
1~10% | 12 (12.0%) | 35 (35.0%) | 11 (11.0%) | 15 (15.0%) |
11~25% | 15 (15.0%) | 16 (16.0%) | 14 (14.0%) | 20 (20.0%) |
> 25% | 13 (13.0%) | 25 (25.0%) | 67 (67.0%) | 50 (50.0%) |